Integer Holdings Co. (NYSE:ITGR) Shares Sold by Jane Street Group LLC

Jane Street Group LLC reduced its stake in shares of Integer Holdings Co. (NYSE:ITGR - Free Report) by 59.5% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 61,378 shares of the medical equipment provider's stock after selling 90,019 shares during the period. Jane Street Group LLC owned approximately 0.18% of Integer worth $8,134,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Emerald Mutual Fund Advisers Trust boosted its holdings in Integer by 0.8% during the fourth quarter. Emerald Mutual Fund Advisers Trust now owns 19,867 shares of the medical equipment provider's stock worth $2,633,000 after buying an additional 152 shares in the last quarter. Lido Advisors LLC raised its position in shares of Integer by 31.4% in the fourth quarter. Lido Advisors LLC now owns 2,742 shares of the medical equipment provider's stock worth $363,000 after acquiring an additional 655 shares during the period. Northern Trust Corp boosted its stake in shares of Integer by 14.2% during the 4th quarter. Northern Trust Corp now owns 422,380 shares of the medical equipment provider's stock worth $55,974,000 after acquiring an additional 52,556 shares in the last quarter. Price T Rowe Associates Inc. MD grew its position in shares of Integer by 14.4% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 22,957 shares of the medical equipment provider's stock valued at $3,043,000 after acquiring an additional 2,891 shares during the period. Finally, Dark Forest Capital Management LP purchased a new position in shares of Integer in the 4th quarter valued at about $336,000. Hedge funds and other institutional investors own 99.29% of the company's stock.

Insider Buying and Selling at Integer

In other news, CEO Joseph W. Dziedzic sold 338,975 shares of Integer stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $123.17, for a total transaction of $41,751,550.75. Following the sale, the chief executive officer now owns 47,000 shares of the company's stock, valued at approximately $5,788,990. The trade was a 87.82 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 2.16% of the stock is currently owned by company insiders.

Integer Price Performance

Shares of Integer stock traded down $1.12 on Friday, hitting $118.40. 334,885 shares of the company were exchanged, compared to its average volume of 364,084. Integer Holdings Co. has a 1-year low of $104.93 and a 1-year high of $146.36. The company has a quick ratio of 2.09, a current ratio of 2.95 and a debt-to-equity ratio of 0.62. The stock has a market capitalization of $4.13 billion, a price-to-earnings ratio of 35.24, a price-to-earnings-growth ratio of 1.72 and a beta of 1.03. The company has a 50-day moving average price of $118.43 and a 200 day moving average price of $129.75.

Integer (NYSE:ITGR - Get Free Report) last issued its earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.27 by $0.04. Integer had a return on equity of 11.65% and a net margin of 6.92%. The company had revenue of $437.39 million during the quarter, compared to analysts' expectations of $428.51 million. During the same period in the prior year, the business earned $1.14 EPS. The firm's quarterly revenue was up 7.3% on a year-over-year basis. As a group, sell-side analysts predict that Integer Holdings Co. will post 6.01 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have commented on the company. StockNews.com lowered Integer from a "hold" rating to a "sell" rating in a report on Friday, April 25th. Benchmark cut their price target on shares of Integer from $150.00 to $140.00 and set a "buy" rating for the company in a report on Friday, April 25th. KeyCorp decreased their price objective on shares of Integer from $154.00 to $145.00 and set an "overweight" rating on the stock in a report on Monday, April 21st. Raymond James boosted their target price on shares of Integer from $145.00 to $150.00 and gave the stock an "outperform" rating in a research note on Friday, April 25th. Finally, Truist Financial set a $150.00 price target on shares of Integer and gave the company a "buy" rating in a research note on Friday, April 25th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat.com, Integer presently has a consensus rating of "Moderate Buy" and a consensus target price of $145.56.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.